Shuttle Pharmaceuticals Holdings (SHPH) Other financing activities (2023 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Other financing activities of $15750.0 in Q1 2026, down 96.5% quarter-over-quarter from $450168.0 in Q4 2025, and down 68.5% on a YoY basis from $50001.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other financing activities (2023 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other financing activities history runs 4 years deep, the most recent figure standing at $15750.0 for Q1 2026.
- In Q1 2026, Other financing activities fell 68.5% year-over-year to $15750.0; the TTM figure through Mar 2026 stood at $523408.0 (up 446.12% YoY), while the FY2025 annual figure was $557659.0, up 418.8% from the prior year.
- Other financing activities was $15750.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $450168.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $476459.0 in Q2 2025 to a low of -$418969.0 in Q3 2025.
- Historically, Other financing activities has averaged $120531.1 across 4 years, with a median of $45000.5 in 2024.
- The sharpest annual moves came in 2024 and 2025: Other financing activities plunged 88.41% in 2024, then jumped 7608.36% in 2025.
- A 4-year view of Other financing activities shows it stood at $345000.0 in 2023, then plunged by 98.31% to $5840.0 in 2024, then surged by 7608.36% to $450168.0 in 2025, then tumbled by 96.5% to $15750.0 in 2026.
- The last three Other financing activities figures came in at $15750.0 (Q1 2026), $450168.0 (Q4 2025), and -$418969.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,750.00 |
| Mar 31, 2026 | 15,750.00 |
| Dec 31, 2025 | 450,168.00 |
| Dec 31, 2025 | 450,168.00 |
| Sep 30, 2025 | -418,969.00 |
| Sep 30, 2025 | -418,969.00 |
| Jun 30, 2025 | 476,459.00 |
| Jun 30, 2025 | 476,459.00 |
| Mar 31, 2025 | 50,001.00 |
| Mar 31, 2025 | 50,001.00 |
| Dec 31, 2024 | 5,840.00 |
| Dec 31, 2024 | 5,840.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2023 | 345,000.00 |
| Mar 31, 2023 | 345,000.00 |